Glioma Archives | Oncotarget.net

Oncotarget News

Bibliometric Mapping Reveals the Evolution of Glioma Classification Research

April 6, 2026

The findings indicate that the subset of articles focusing on glioma classification that incorporate social factors is relatively scarce in the analyzed data, in contrast to the prominence of epigenetic... read more

Oncotarget

Lower LRIG1 Expression Linked to Aggressive Gliomas

November 12, 2025

Our results reinforce suggestions that LRIG1-3 could function as diagnostic markers and therapeutic targets in the treatment of gliomas.”BUFFALO, NY - November 12, 2025 – A new research paper was published... read more

Oncotarget

Triple Therapy Slows Glioblastoma Growth and Extends Survival in Preclinical Study

April 4, 2025

Our findings demonstrate for the first time that IRT therapy combining ONC201 or ONC206 with RT and TMZ may be a safe and effective therapeutic strategy for GBM.”BUFFALO, NY -... read more

Oncotarget

Zika Virus as a Treatment for Brain Cancer: A Systematic Review

October 9, 2024

Despite limited human evidence, it shows potential benefits.”BUFFALO, NY- October 9, 2024 – A new review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, “Zika virus and... read more

Figure 2: BCAS1+ cells in diffuse gliomas are morphologically different from BCAS1+ cells in healthy brain tissue.

Oncotarget

BCAS1 Defines a Heterogeneous Cell Population in Diffuse Glioma Patients

January 31, 2024

this is the first study describing a BCAS1+ cell population in a large cohort of diffuse glioma patients.”BUFFALO, NY- January 31, 2024 – A new research paper was published in... read more

Figure 1: (A) Canonical STAT3 activation pathway. (B) WP1066 and TTI-101, examples of small molecule STAT3 inhibitors that are cell penetrant.

Oncotarget

STAT3 as a Target in H3K27M-mutant DMGs

October 9, 2023

Children diagnosed with these tumors have [...] a median survival of approximately 12 months.” BUFFALO, NY- October 9, 2023 – A new editorial perspective was published in Oncotarget's Volume 14 on... read more

Oncotarget

Behind the Study: Extending Survival in Glioma Models

May 10, 2021

Behind the Study is a series of transcribed videos from researchers elaborating on their recent oncology-focused studies published by Oncotarget. A new Behind the Study is released each... read more

Oncotarget

Behind the Study: Critical Role STAT3 Plays in Glioma-initiating Cells

February 8, 2021

The head chair of pathology and a graduate research assistant from the University of Tennessee Health Science Center detail their paper published in Oncotarget titled, "The critical role that STAT3... read more